Overview
- The University of Oxford analysis found patients using older GLP-1 drugs regained their lost weight within 10 months of discontinuation.
- Newer, high-dose drugs like Wegovy and Mounjaro led to greater initial weight loss but showed substantial regain, with patients typically regaining 10kg within a year and full rebound projected in 18–20 months.
- The study examined data from 6,370 adults across 11 trials and highlighted that weight regain after stopping GLP-1 drugs is significantly faster than after diets, where weight returns over at least five years.
- Experts stress that patients discontinuing weight-loss jabs need psychological counseling, behavioral changes, and nutritional support to sustain long-term weight loss.
- The findings challenge the NHS’s two-year prescription limit, with calls for either lifelong drug use or enhanced post-treatment support to prevent rapid weight rebound.